How MPNs progress to AML and how to stop it
Thrive Award Spotlight: John Crispino, St. Jude Children’s Research HospitalCo-PI – Ayalew Tefferi, Mayo Clinic, MN Aberrant Megakaryopoiesis in the MPNs According to Leukemia &
Thrive Award Spotlight: John Crispino, St. Jude Children’s Research HospitalCo-PI – Ayalew Tefferi, Mayo Clinic, MN Aberrant Megakaryopoiesis in the MPNs According to Leukemia &
Shannon Elf, PhD, University of Utah Huntsman Cancer Institute The metabolic landscape of MPNs is an extremely understudied area in the field. Solid
The world of myeloproliferative neoplasms (MPNs) has witnessed a surge in scientific breakthroughs. From detecting genetic drivers as early as in the fetus to the unprecedented pace of
We celebrate two members of our Board of Directors recently named MPN Heroes during the Annual Meeting of the American Society of Hematology (ASH). Dr.
Each year at the Annual Meeting of The American Society of Hematology (ASH), there are more MPN research and clinical trial reports. This year, some